These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 3350995)

  • 1. Mechanism of cephalosporin-induced hypoprothrombinemia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status.
    Shearer MJ; Bechtold H; Andrassy K; Koderisch J; McCarthy PT; Trenk D; Jähnchen E; Ritz E
    J Clin Pharmacol; 1988 Jan; 28(1):88-95. PubMed ID: 3350995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hemostasis disturbance caused by cephalosporins with an N-methylthiotetrazole side chain. A randomized pilot study].
    Schäfer H; Naber K; Adam D
    Arzneimittelforschung; 1989 Sep; 39(9):1156-62. PubMed ID: 2590268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of cefoxitin and cefotetan on vitamin K metabolism.
    Sieradzan RR; Bottner WA; Fasco MJ; Bertino JS
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1446-9. PubMed ID: 3196007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of effect of cefixime on the metabolism of vitamin K1.
    Trenk D; Wagner F; Bechtold H; Nies B; Jähnchen E
    J Clin Pharmacol; 1990 Aug; 30(8):737-42. PubMed ID: 2401753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of N-methyl-thiotetrazole cephalosporin on haemostasis in patients with reduced serum vitamin K1 concentrations.
    Mackie IJ; Walshe K; Cohen H; McCarthy P; Shearer M; Scott SD; Karran SJ; Machin SJ
    J Clin Pathol; 1986 Nov; 39(11):1245-9. PubMed ID: 3466904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoprothrombinemia associated with cefmetazole.
    Breen GA; St Peter WL
    Ann Pharmacother; 1997 Feb; 31(2):180-4. PubMed ID: 9034420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Association Between Cephalosporin and Hypoprothrombinemia: A Systematic Review and Meta-Analysis.
    Park GH; Kim S; Kim MS; Yu YM; Kim GH; Lee JS; Lee E
    Int J Environ Res Public Health; 2019 Oct; 16(20):. PubMed ID: 31623191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible coumarin-like mechanism of action for cephalosporins.
    Bechtold H; Lorenz J; Weilemann LS; Meinertz T; Trenk D; Andrassy K; Jähnchen E
    Klin Wochenschr; 1984 Sep; 62(18):885-6. PubMed ID: 6492697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cephalosporin-induced hypoprothrombinemia: is the N-methylthiotetrazole side chain the culprit?
    Agnelli G; Del Favero A; Parise P; Guerciolini R; Pasticci B; Nenci GG; Ofosu F
    Antimicrob Agents Chemother; 1986 Jun; 29(6):1108-9. PubMed ID: 3729364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of antibiotic-associated hypoprothrombinemia.
    Schentag JJ; Welage LS; Grasela TH; Adelman MH
    Pharmacotherapy; 1987; 7(3):80-6. PubMed ID: 3306622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired hemostasis caused by beta-lactam antibiotics.
    Sattler FR; Weitekamp MR; Sayegh A; Ballard JO
    Am J Surg; 1988 May; 155(5A):30-9. PubMed ID: 3287966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of warfarin on plasma and liver vitamin K levels and vitamin K epoxide reductase activity in relation to plasma clotting factor levels in rats.
    Yamanaka Y; Yamano M; Yasunaga K; Shike T; Uchida K
    Thromb Res; 1990 Jan; 57(2):205-14. PubMed ID: 2315885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for impaired hepatic vitamin K1 metabolism in patients treated with N-methyl-thiotetrazole cephalosporins.
    Bechtold H; Andrassy K; Jähnchen E; Koderisch J; Koderisch H; Weilemann LS; Sonntag HG; Ritz E
    Thromb Haemost; 1984 Jul; 51(3):358-61. PubMed ID: 6548584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of hypoprothrombinaemia following antibiotic therapy in malnourished patients with low serum vitamin K1 levels.
    Cohen H; Scott SD; Mackie IJ; Shearer M; Bax R; Karran SJ; Machin SJ
    Br J Haematol; 1988 Jan; 68(1):63-6. PubMed ID: 3422816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a vitamin K-deficient diet and antibiotics in normal human volunteers.
    Allison PM; Mummah-Schendel LL; Kindberg CG; Harms CS; Bang NU; Suttie JW
    J Lab Clin Med; 1987 Aug; 110(2):180-8. PubMed ID: 3598347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin K1 metabolism and the production of des-carboxy prothrombin and protein C in the term and premature neonate.
    Bovill EG; Soll RF; Lynch M; Bhushan F; Landesman M; Freije M; Church W; McAuliffe T; Davidson K; Sadowski J
    Blood; 1993 Jan; 81(1):77-83. PubMed ID: 8417804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of N-methyl-thiotetrazole on vitamin K epoxide reductase.
    Creedon KA; Suttie JW
    Thromb Res; 1986 Oct; 44(2):147-53. PubMed ID: 3787564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin K reversible hypoprothrombinemia in rats. II. Efficacy of vitamin K on latamoxef-induced coagulopathy in rats.
    Matsuura M; Satoh S; Kobayashi F; Matsubara T; Uchida K
    Jpn J Pharmacol; 1988 Aug; 47(4):357-65. PubMed ID: 3184567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulant effects of warfarin and kinetics of K vitamins in blood and feces.
    Nakamura K; Toyohira H; Kariyazono H; Ishibashi M; Saigenji H; Shimokawa S; Taira A
    Artery; 1994; 21(3):148-60. PubMed ID: 7794122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin K1 metabolism in relation to pharmacodynamic response in anticoagulated patients.
    Choonara IA; Scott AK; Haynes BP; Cholerton S; Breckenridge AM; Park BK
    Br J Clin Pharmacol; 1985 Dec; 20(6):643-8. PubMed ID: 4091996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.